A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy

NCT00426348 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Glomerulonephritis
IGA Nephropathy

Interventions

DRUG: Valsartan
DRUG: Probucol
DRUG: Placebo

Sponsor

Guangdong Provincial People's Hospital